Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ZURA

Zura Bio (ZURA)

Zura Bio Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ZURA
DateTimeSourceHeadlineSymbolCompany
09/05/202420:00Business WireZura Bio Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:ZURAZura Bio Ltd
18/04/202423:22Business WireZura Bio Announces Oversubscribed $112.5 Million Private PlacementNASDAQ:ZURAZura Bio Ltd
08/04/202420:00Business WireZura Bio Announces Robert Lisicki as CEO and DirectorNASDAQ:ZURAZura Bio Ltd
28/03/202421:00Business WireZura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive OfficerNASDAQ:ZURAZura Bio Ltd
04/03/202422:00Business WireZura Bio Announces Participation at March ConferencesNASDAQ:ZURAZura Bio Ltd
24/02/202408:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
15/02/202401:02Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ZURAZura Bio Ltd
02/02/202422:00Business WireZura Bio Announces Participation at February Investor ConferencesNASDAQ:ZURAZura Bio Ltd
27/01/202403:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZURAZura Bio Ltd
27/01/202403:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZURAZura Bio Ltd
27/01/202403:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZURAZura Bio Ltd
12/01/202409:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
08/01/202422:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
08/01/202422:00Business WireZura Bio Continues to Strengthen Leadership with Appointment of Robert Lisicki as President and Kiran Nistala as CMONASDAQ:ZURAZura Bio Ltd
03/01/202422:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
03/01/202422:00Business WireZura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology SummitNASDAQ:ZURAZura Bio Ltd
04/12/202322:00Business WireZura Bio Announces Two Immunology Abstracts Presented at the World Allergy Congress in BangkokNASDAQ:ZURAZura Bio Ltd
18/11/202309:53Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ZURAZura Bio Ltd
14/11/202322:00Business WireZura Bio Appoints Arnout Ploos van Amstel to its Board of DirectorsNASDAQ:ZURAZura Bio Ltd
13/11/202322:30Business WireZura Bio Reports Third Quarter 2023 Financial Results and Recent Business HighlightsNASDAQ:ZURAZura Bio Ltd
26/10/202307:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
03/10/202312:54Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ZURAZura Bio Ltd
03/10/202312:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
15/09/202314:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ZURAZura Bio Ltd
15/09/202307:01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ZURAZura Bio Ltd
15/09/202306:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
12/09/202319:00Business WireZura Bio Enters into Sponsored Research Agreement with Benaroya Research InstituteNASDAQ:ZURAZura Bio Ltd
25/08/202311:54Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ZURAZura Bio Ltd
14/08/202321:00Business WireZura Bio Reports Second Quarter 2023 Financial Results and Recent Business HighlightsNASDAQ:ZURAZura Bio Ltd
12/08/202307:13Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ZURAZura Bio Ltd
 Showing the most relevant articles for your search:NASDAQ:ZURA